Skip to main content
. Author manuscript; available in PMC: 2015 Feb 28.
Published in final edited form as: Toxicology. 2013 Dec 26;316:14–24. doi: 10.1016/j.tox.2013.12.001

Table 2.

Predicted upstream regulators of genes altered by B[a]P treatment.

Upstream Regulator Predicted Activation State Activation z-score p-value of overlap
benzo(a)pyrene Activated 4.15 6.90E-23
cigarette smoke Activated 2.80 1.22E-18
cisplatin Activated 3.14 3.91E-15
chromium Inhibited −4.24 5.51E-15
camptothecin Activated 6.20 5.97E-15
arsenite 1.69 4.51E-14
tert-butyl-hydroquinone Activated 3.90 1.05E-13
TP53 Activated 4.35 4.60E-13
sulforafan Activated 2.05 7.47E-13
nitric oxide Activated 4.26 4.27E-11
PDGFBB Activated 2.97 6.69E-11
FGF1 Activated 4.11 9.82E-11
hydrogen peroxide Activated 3.34 1.59E-10
HGF −0.56 1.78E-10
NUPR1 Activated 3.43 2.59E-10
BRCA1 Activated 2.17 3.96E-10
U0126 −1.56 4.61E-10
TNF 1.83 6.13E-10
doxorubicin Activated 2.06 8.63E-10
beta-naphthoflavone Activated 3.56 1.06E-09
AHR Activated 2.96 2.07E-09
tetrachlorodibenzodioxin Activated 3.58 2.12E-09

The z-score predicts activation state; the p-value measures the statistical significance of the prediction.